Literature DB >> 32047369

Evidence-Based Psychotherapies for Bipolar Disorder.

Danielle M Novick1, Holly A Swartz1.   

Abstract

Bipolar disorder is a recurrent psychiatric disorder marked by waxing and waning affective symptoms and impairment in functioning. Some of the morbidity and mortality associated with the illness may be reduced with evidence-based psychotherapies (EBPs) along with pharmacotherapy. To enhance clinicians' understanding of which therapy modalities have evidence supporting their use, the authors conducted a systematic literature review to identify randomized controlled trials (RCTs) of psychotherapy for adults with bipolar disorder. A strong evidence base exists for psychoeducation, cognitive-behavioral therapy, family-focused therapy, interpersonal and social rhythm therapy, and peer-support programs. Promising modalities include functional remediation, mindfulness-based cognitive therapy, illness management and recovery, and technology-assisted strategies. RCTs demonstrate a consistent advantage of these psychotherapies plus pharmacotherapy, compared with the use of pharmacotherapy alone. Adjunctive EBPs hasten time to remission, delay time to recurrence, and improve functional outcomes. EBPs play an important role in helping individuals develop skills needed to manage the persistent and lifelong psychosocial, neurocognitive, vocational, and interpersonal consequences of bipolar disorder. Continued efforts to improve the effectiveness of EBPs for adults with bipolar disorder are warranted.
Copyright © by the American Psychiatric Association.

Entities:  

Keywords:  Mood Disorders-Bipolar; Psychotherapy; cognitive-behavioral therapy; interpersonal and social rhythm therapy; psychoeducation

Year:  2019        PMID: 32047369      PMCID: PMC6999214          DOI: 10.1176/appi.focus.20190004

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  88 in total

Review 1.  Illness management and recovery: a review of the literature.

Authors:  Alan B McGuire; Marina Kukla; Amethyst Green; Daniel Gilbride; Kim T Mueser; Michelle P Salyers
Journal:  Psychiatr Serv       Date:  2014-02-01       Impact factor: 3.084

2.  Evaluation of the Illness Management and Recovery Scale in schizophrenia and schizoaffective disorder.

Authors:  Rickard Färdig; Tommy Lewander; Anders Fredriksson; Lennart Melin
Journal:  Schizophr Res       Date:  2011-07-27       Impact factor: 4.939

3.  Implementing interpersonal and social rhythm therapy for mood disorders across a continuum of care.

Authors:  Holly A Swartz; Ellen Frank; Kelly O'Toole; Nathan Newman; Helen Kiderman; Scott Carlson; Janis W Fink; Yu Cheng; Catherine C Maihoefer; Kelly Forster Wells; Patricia R Houck; Tiffany Painter; Sara H Ortenzio; Stacy L Simon; Perry Henschke; Frank Ghinassi
Journal:  Psychiatr Serv       Date:  2011-11       Impact factor: 3.084

4.  Effectiveness of peer-delivered Center for Independent Living supports for individuals with psychiatric disabilities: A randomized, controlled trial.

Authors:  Mark S Salzer; Joseph Rogers; Nancy Salandra; Conor O'Callaghan; Fran Fulton; Alyssa A Balletta; Katie Pizziketti; Eugene Brusilovskiy
Journal:  Psychiatr Rehabil J       Date:  2016-09

5.  Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder.

Authors:  Ellen Frank; David J Kupfer; Michael E Thase; Alan G Mallinger; Holly A Swartz; Andrea M Fagiolini; Victoria Grochocinski; Patricia Houck; John Scott; Wesley Thompson; Timothy Monk
Journal:  Arch Gen Psychiatry       Date:  2005-09

6.  The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study.

Authors:  Rafael Thomaz da Costa; Elie Cheniaux; Pedro Augusto Legnani Rosaes; Marcele Regine de Carvalho; Rafael Christophe da Rocha Freire; Márcio Versiani; Bernard Pimentel Rangé; Antonio Egidio Nardi
Journal:  Braz J Psychiatry       Date:  2011-06       Impact factor: 2.697

Review 7.  Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression.

Authors:  C L Ehlers; E Frank; D J Kupfer
Journal:  Arch Gen Psychiatry       Date:  1988-10

8.  Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial.

Authors:  Margaret M Rea; Martha C Tompson; David J Miklowitz; Michael J Goldstein; Sun Hwang; Jim Mintz
Journal:  J Consult Clin Psychol       Date:  2003-06

9.  A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.

Authors:  Francesco Colom; Eduard Vieta; Anabel Martinez-Aran; Maria Reinares; Jose Manuel Goikolea; Antonio Benabarre; Carla Torrent; Merce Comes; Barbara Corbella; Gemma Parramon; Josep Corominas
Journal:  Arch Gen Psychiatry       Date:  2003-04

10.  Effects of adjunctive peer support on perceptions of illness control and understanding in an online psychoeducation program for bipolar disorder: a randomised controlled trial.

Authors:  Judith Proudfoot; Gordon Parker; Vijaya Manicavasagar; Dusan Hadzi-Pavlovic; Alexis Whitton; Jennifer Nicholas; Meg Smith; Rowan Burckhardt
Journal:  J Affect Disord       Date:  2012-08-02       Impact factor: 4.839

View more
  3 in total

1.  Adjuvant psychotherapy in early-stage bipolar disorder: A protocol for systematic review and meta-analysis.

Authors:  Qianfang Chen; Yuanyue Zhou; Huifen Lv; Caie Ma
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

2.  Psychoeducation in bipolar disorder: A systematic review.

Authors:  Juliana Lemos Rabelo; Breno Fiuza Cruz; Jéssica Diniz Rodrigues Ferreira; Bernardo de Mattos Viana; Izabela Guimarães Barbosa
Journal:  World J Psychiatry       Date:  2021-12-19

Review 3.  Therapeutic Application of Lithium in Bipolar Disorders: A Brief Review.

Authors:  Zubair Mahmood Kamal; Siddhartha Dutta; Sayeeda Rahman; Ayukafangha Etando; Emran Hasan; Sayeda Nazmun Nahar; Wan Farizatul Shima Wan Ahmad Fakuradzi; Susmita Sinha; Mainul Haque; Rahnuma Ahmad
Journal:  Cureus       Date:  2022-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.